相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature
William E. Monaco et al.
CLINICAL RHEUMATOLOGY (2016)
Late-onset neutropenia after rituximab in ANCA-associated vasculitis
A. Knight et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2016)
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
J. H. Salmon et al.
RMD OPEN (2015)
Late-onset neutropenia following rituximab treatment for rheumatologic conditions
Gabriel S. Breuer et al.
CLINICAL RHEUMATOLOGY (2014)
Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab
Rita Abdulkader et al.
JOURNAL OF RHEUMATOLOGY (2014)
Interferon-alpha-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes
Patricia Lopez et al.
RHEUMATOLOGY (2014)
Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response
Thorunn Jonsdottir et al.
RHEUMATOLOGY (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Neutropenia after rituximab treatment: new insights on a late complication
Ofir Wolach et al.
CURRENT OPINION IN HEMATOLOGY (2012)
American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Bevra H. Hahn et al.
ARTHRITIS CARE & RESEARCH (2012)
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Daniel Tesfa et al.
ARTHRITIS AND RHEUMATISM (2011)
Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow
Thomas Matthes et al.
BLOOD (2011)
Neutropenia associated with rituximab therapy
Cliona Grant et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Current and novel therapeutics in the treatment of systemic lupus erythematosus
Cagri Yildirim-Toruner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
B Cell and BAFF Dependence of IFN-α-Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
Noam Jacob et al.
JOURNAL OF IMMUNOLOGY (2011)
Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis
Joseph E. Craft
SCIENCE TRANSLATIONAL MEDICINE (2011)
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
Roberto Lande et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms
Daniel Tesfa et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Late-Onset Neutropenia After Rituximab Treatment Case Series and Comprehensive Review of the Literature
Ofir Wolach et al.
MEDICINE (2010)
Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
John N. Boletis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
Daniel Tesfa et al.
MEDICAL ONCOLOGY (2008)
Treatment of refractory SLE with rituximab plus cyclophosphamide:: clinical effects, serological changes, and predictors of response
T. Jonsdottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery
B. Terrier et al.
HAEMATOLOGICA (2007)
Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma
Kenji Fukuno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
K Dunleavy et al.
BLOOD (2005)
Identification of proteoglycans as the APRIL-specific binding partners
K Ingold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
B lymphocyte depletion therapy with rituximab in rheumatoid arthritis
JCW Edwards et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway
MK Richards et al.
BLOOD (2003)
Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus
Y Ren et al.
ARTHRITIS AND RHEUMATISM (2003)
Delayed-onset neutropenia associated with rituximab therapy
K Chaiwatanatorn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases
T Papadaki et al.
LEUKEMIA RESEARCH (2002)